A Pilot Study of Sequential Vaccinations With ALVAC-CEA and Vaccinia-CEA With the Addition of IL-2 [interleukin-2] and GM-CSF [granulocyte-macrophage colony-stimulating factors] in Patients With CEA Expressing Tumors
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2016
At a glance
- Drugs ALVAC CEA (Primary) ; Vaccinia CEA (Primary) ; Interleukin-2; Sargramostim
- Indications Cancer
- Focus Pharmacodynamics
- 04 Nov 2005 New trial record.